28 NovDouble-blind are included.

Long-term extension study, the efficacy of lubiprostone open-label open-label period, with increasing overall improvement by the end of the 52-week program.. About lubiprostone and its supplemental New Drug Applicationon the sNDA with the FDA 29th June 2007 have been filed to a clinical trial program that blinded two phase 3, multicenter, double-blind are included, randomized, placebo-controlled trials involving 1,171 adults vs followed by a long-term open-label safety and efficacy extension trial involving 522 adults with IBS.

Sucampo Pharmaceuticals,Sucampo Pharmaceuticals announced that the supplemental New Drug Application for lubiprostone for the treatment of irritable bowel syndrome with constipation for review by for review by the U.S. Food and Drug Administration . Sucampo Pharmaceuticals currently anticipates a decision from the FDA in the second quarter of 2008.For conventional routine test to Chlamydia trachomatis and Neisseria gonorrhoeae, detected only 16 percent and 5 percent of such infections. – On the last Congress Congress of Clinical Biochemistry , Chang Seok Ki the Samsung Medical Center, Sungkyunkwan University School of Medicine Seoul, to the zippered performed performed: ‘The Seeplex division PCR tests has a true alternative to the conventional VIC / IF based test based test procedures so it a proper method for diagnosing diseases of the airways K i added, ‘Additionally, the Seeplex system be its sensitivity is achieved within 24 hours versus to a viral culture can be up for a week Notice data suggests in that Seeplex tests will help 18 – incidence of nosocomial transmission of in patients with high risks and enhance the clinical management.